Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Cannapharmarx Inc (CPMD)

Cannapharmarx Inc (CPMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Cannabis Cultivation Revenue Continues to Climb as Demand & Usage Grows Across North America FinancialNewsMedia - Wed Dec 21, 2022

EQNX::TICKER_START (OTCPK:CPMD),(OTCQX:TCNNF),(OTCQX:CURLF),(NASDAQ:TLRY),(NASDAQ:ACB) EQNX::TICKER_END

TCNNF : 10.5700 (+3.83%)
TRUL : 0.0001 (unch)
TRUL.CN : 14.3700 (+4.13%)
CPMD : 0.0100 (-31.03%)
CURLF : 5.0000 (+5.26%)
CURA.CN : 5.2200 (+9.21%)
TLRY : 1.7800 (+1.71%)
TLRY.TO : 2.43 (+0.83%)
ACB : 6.70 (-0.15%)
ACB.TO : 9.19 (+0.33%)
Cannabis Cultivation Revenue Continues to Climb as Demand & Usage Grows Across North America PR Newswire - Wed Dec 21, 2022

/PRNewswire/ -- The global cannabis cultivation market has grown significantly during the COVID-19 pandemic. The demand for hemp is rapidly growing, as many...

TCNNF : 10.5700 (+3.83%)
CPMD : 0.0100 (-31.03%)
CURA.CN : 5.2200 (+9.21%)
TLRY.TO : 2.43 (+0.83%)
ACB.TO : 9.19 (+0.33%)
CURLF : 5.0000 (+5.26%)
TLRY : 1.7800 (+1.71%)
ACB : 6.70 (-0.15%)
CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Annual Revenue over $30 Million FinancialNewsMedia - Wed Dec 21, 2022

Calgary, AB – December 21, 2022 – CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today it received its cultivation license...

CPMD : 0.0100 (-31.03%)
CannaPharmaRx Secures New Strains for Declaration to be Incorporated Into Product Portfolio FinancialNewsMedia - Mon Dec 19, 2022

Calgary, AB – December 19, 2022 – CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today it has secured new genetic strains...

CPMD : 0.0100 (-31.03%)
CannaPharmaRx Enters into a Genetics Transfer Agreement with High Profile Cannabis Corp. AccessWire - Wed Jun 29, 2022

CALGARY, AB / ACCESSWIRE / June 29, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has signed a genetics...

CPMD : 0.0100 (-31.03%)
CannaPharmaRx Acquiring Oklahoma Cannabis Facility AccessWire - Thu Feb 10, 2022

CALGARY, AB / ACCESSWIRE / February 10, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has signed a...

CPMD : 0.0100 (-31.03%)
CannaPharmaRx Stops Issuing Shares Under Previously Effective S-1 AccessWire - Tue Feb 8, 2022

CALGARY, AB / ACCESSWIRE / February 8, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced today that it will...

CPMD : 0.0100 (-31.03%)
CannaPharmaRx Enters into an Agreement for Supply of Genetics and Feed Stock to Accelerate Time to Market AccessWire - Tue Jan 25, 2022

CALGARY, AB / ACCESSWIRE / January 25, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced today they have entered...

CPMD : 0.0100 (-31.03%)
CannaPharmaRx Hires Key Personnel to Accelerate Output and Speed to Market for Cannabis Product AccessWire - Wed Jan 19, 2022

CALGARY, AB / ACCESSWIRE / January 19, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced today the hiring...

CPMD : 0.0100 (-31.03%)
CannaPharmaRx Completes Long Term Lease for Cremona Production Facility Which Should Yield 6,000Kg ($30,000,000)/Year AccessWire - Thu Jan 6, 2022

CALGARY, AB / ACCESSWIRE / January 6, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced today the completion...

CPMD : 0.0100 (-31.03%)

Barchart Exclusives

Is Amgen Stock a Buy for Its 3% Yield? Barchart - 2 minutes ago
Amgen’s stock offers investors a yield slightly above 3%, supported by 12 years of consistent growth. Despite a 6% year-to-date decline, the stock is rated as a moderate buy with a potential 12% upside to the mean price target, and its development of AMG133 for obesity treatment adds to its appeal. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot